Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I
- 10 May 2003
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 361 (9369), 1608-1613
- https://doi.org/10.1016/s0140-6736(03)13311-9
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Enzyme Replacement Therapy in Mucopolysaccharidosis I: Altered Distribution and Targeting of α-
l -Iduronidase in Immunized RatsMolecular Genetics and Metabolism, 2000 - Immune Response to Enzyme Replacement Therapy in Lysosomal Storage Disorder Patients and Animal ModelsMolecular Genetics and Metabolism, 1999
- Immune Response to Enzyme Replacement Therapy: 4-Sulfatase Epitope Reactivity of Plasma Antibodies from MPS VI CatsMolecular Genetics and Metabolism, 1999
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.JCI Insight, 1998
- Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.JCI Insight, 1997
- Current Issues in Enzyme Therapy for Gaucher DiseaseDrugs, 1996
- Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.JCI Insight, 1996
- Enzyme replacement therapy for murine mucopolysaccharidosis type VII.JCI Insight, 1994
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Enzyme Therapy: Problems and SolutionsAnnual Review of Biochemistry, 1982